Global Pharmaceutical Intermediates Market Research Report 2022(Status and Outlook)

June 2022 | 122 pages | ID: G49935EF0F72EN
Bosson Research

Abstracts

Report Overview

Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.

Global Pharmaceutical Intermediates key players include Wartsila, Hyundai, MAN, MES, Caterpillar, etc. Global top three manufacturers hold a share over 45%.

China is the largest production area, with a share about 3%, followed by India and North America, both have a share over 4 percent.

In terms of product, GMP is the largest segment, with a share over 8%. And in terms of application, the largest application is Antibiotics, followed by Antipyretic analgesics, etc.

The Global Pharmaceutical Intermediates Market Size was estimated at USD 171398.33 million in 2021 and is projected to reach USD 263961.53 million by 2028, exhibiting a CAGR of 6.36% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Pharmaceutical Intermediates market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmaceutical Intermediates Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmaceutical Intermediates market in any manner.

Global Pharmaceutical Intermediates Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

• Lonza
• Catalent
• Patheon
• Jubilant
• Granules
• Ganesh
• Chemcon
• BASF
• Porton
• Lianhetech
• ABA Chem
• Tianma
• Jiujiujiu
• Alpha
• Jiuzhou
• Yongtai

Market Segmentation (by Type)

• GMP
• Non-GMP

Market Segmentation (by Application)

• Antibiotics
• Antipyretic Analgesics
• Vitamins
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Pharmaceutical Intermediates Market
• Overview of the regional outlook of the Pharmaceutical Intermediates Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmaceutical Intermediates Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Pharmaceutical Intermediates
1.2 Key Market Segments
  1.2.1 Pharmaceutical Intermediates Segment by Type
  1.2.2 Pharmaceutical Intermediates Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PHARMACEUTICAL INTERMEDIATES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Pharmaceutical Intermediates Market Size (M USD) Estimates and Forecasts (2017-2028)
  2.1.2 Global Pharmaceutical Intermediates Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PHARMACEUTICAL INTERMEDIATES MARKET COMPETITIVE LANDSCAPE

3.1 Global Pharmaceutical Intermediates Sales by Manufacturers (2017-2022)
3.2 Global Pharmaceutical Intermediates Revenue Market Share by Manufacturers (2017-2022)
3.3 Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmaceutical Intermediates Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Pharmaceutical Intermediates Sales Sites, Area Served, Product Type
3.6 Pharmaceutical Intermediates Market Competitive Situation and Trends
  3.6.1 Pharmaceutical Intermediates Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Pharmaceutical Intermediates Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 PHARMACEUTICAL INTERMEDIATES INDUSTRY CHAIN ANALYSIS

4.1 Pharmaceutical Intermediates Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PHARMACEUTICAL INTERMEDIATES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 PHARMACEUTICAL INTERMEDIATES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmaceutical Intermediates Sales Market Share by Type (2017-2022)
6.3 Global Pharmaceutical Intermediates Market Size Market Share by Type (2017-2022)
6.4 Global Pharmaceutical Intermediates Price by Type (2017-2022)

7 PHARMACEUTICAL INTERMEDIATES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmaceutical Intermediates Market Sales by Application (2017-2022)
7.3 Global Pharmaceutical Intermediates Market Size (M USD) by Application (2017-2022)
7.4 Global Pharmaceutical Intermediates Sales Growth Rate by Application (2017-2022)

8 PHARMACEUTICAL INTERMEDIATES MARKET SEGMENTATION BY REGION

8.1 Global Pharmaceutical Intermediates Sales by Region
  8.1.1 Global Pharmaceutical Intermediates Sales by Region
  8.1.2 Global Pharmaceutical Intermediates Sales Market Share by Region
8.2 North America
  8.2.1 North America Pharmaceutical Intermediates Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Pharmaceutical Intermediates Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Pharmaceutical Intermediates Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Pharmaceutical Intermediates Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Pharmaceutical Intermediates Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILED

9.1 Lonza
  9.1.1 Lonza Pharmaceutical Intermediates Basic Information
  9.1.2 Lonza Pharmaceutical Intermediates Product Overview
  9.1.3 Lonza Pharmaceutical Intermediates Product Market Performance
  9.1.4 Lonza Business Overview
  9.1.5 Lonza Pharmaceutical Intermediates SWOT Analysis
  9.1.6 Lonza Recent Developments
9.2 Catalent
  9.2.1 Catalent Pharmaceutical Intermediates Basic Information
  9.2.2 Catalent Pharmaceutical Intermediates Product Overview
  9.2.3 Catalent Pharmaceutical Intermediates Product Market Performance
  9.2.4 Catalent Business Overview
  9.2.5 Catalent Pharmaceutical Intermediates SWOT Analysis
  9.2.6 Catalent Recent Developments
9.3 Patheon
  9.3.1 Patheon Pharmaceutical Intermediates Basic Information
  9.3.2 Patheon Pharmaceutical Intermediates Product Overview
  9.3.3 Patheon Pharmaceutical Intermediates Product Market Performance
  9.3.4 Patheon Business Overview
  9.3.5 Patheon Pharmaceutical Intermediates SWOT Analysis
  9.3.6 Patheon Recent Developments
9.4 Jubilant
  9.4.1 Jubilant Pharmaceutical Intermediates Basic Information
  9.4.2 Jubilant Pharmaceutical Intermediates Product Overview
  9.4.3 Jubilant Pharmaceutical Intermediates Product Market Performance
  9.4.4 Jubilant Business Overview
  9.4.5 Jubilant Pharmaceutical Intermediates SWOT Analysis
  9.4.6 Jubilant Recent Developments
9.5 Granules
  9.5.1 Granules Pharmaceutical Intermediates Basic Information
  9.5.2 Granules Pharmaceutical Intermediates Product Overview
  9.5.3 Granules Pharmaceutical Intermediates Product Market Performance
  9.5.4 Granules Business Overview
  9.5.5 Granules Pharmaceutical Intermediates SWOT Analysis
  9.5.6 Granules Recent Developments
9.6 Ganesh
  9.6.1 Ganesh Pharmaceutical Intermediates Basic Information
  9.6.2 Ganesh Pharmaceutical Intermediates Product Overview
  9.6.3 Ganesh Pharmaceutical Intermediates Product Market Performance
  9.6.4 Ganesh Business Overview
  9.6.5 Ganesh Recent Developments
9.7 Chemcon
  9.7.1 Chemcon Pharmaceutical Intermediates Basic Information
  9.7.2 Chemcon Pharmaceutical Intermediates Product Overview
  9.7.3 Chemcon Pharmaceutical Intermediates Product Market Performance
  9.7.4 Chemcon Business Overview
  9.7.5 Chemcon Recent Developments
9.8 BASF
  9.8.1 BASF Pharmaceutical Intermediates Basic Information
  9.8.2 BASF Pharmaceutical Intermediates Product Overview
  9.8.3 BASF Pharmaceutical Intermediates Product Market Performance
  9.8.4 BASF Business Overview
  9.8.5 BASF Recent Developments
9.9 Porton
  9.9.1 Porton Pharmaceutical Intermediates Basic Information
  9.9.2 Porton Pharmaceutical Intermediates Product Overview
  9.9.3 Porton Pharmaceutical Intermediates Product Market Performance
  9.9.4 Porton Business Overview
  9.9.5 Porton Recent Developments
9.10 Lianhetech
  9.10.1 Lianhetech Pharmaceutical Intermediates Basic Information
  9.10.2 Lianhetech Pharmaceutical Intermediates Product Overview
  9.10.3 Lianhetech Pharmaceutical Intermediates Product Market Performance
  9.10.4 Lianhetech Business Overview
  9.10.5 Lianhetech Recent Developments
9.11 ABA Chem
  9.11.1 ABA Chem Pharmaceutical Intermediates Basic Information
  9.11.2 ABA Chem Pharmaceutical Intermediates Product Overview
  9.11.3 ABA Chem Pharmaceutical Intermediates Product Market Performance
  9.11.4 ABA Chem Business Overview
  9.11.5 ABA Chem Recent Developments
9.12 Tianma
  9.12.1 Tianma Pharmaceutical Intermediates Basic Information
  9.12.2 Tianma Pharmaceutical Intermediates Product Overview
  9.12.3 Tianma Pharmaceutical Intermediates Product Market Performance
  9.12.4 Tianma Business Overview
  9.12.5 Tianma Recent Developments
9.13 Jiujiujiu
  9.13.1 Jiujiujiu Pharmaceutical Intermediates Basic Information
  9.13.2 Jiujiujiu Pharmaceutical Intermediates Product Overview
  9.13.3 Jiujiujiu Pharmaceutical Intermediates Product Market Performance
  9.13.4 Jiujiujiu Business Overview
  9.13.5 Jiujiujiu Recent Developments
9.14 Alpha
  9.14.1 Alpha Pharmaceutical Intermediates Basic Information
  9.14.2 Alpha Pharmaceutical Intermediates Product Overview
  9.14.3 Alpha Pharmaceutical Intermediates Product Market Performance
  9.14.4 Alpha Business Overview
  9.14.5 Alpha Recent Developments
9.15 Jiuzhou
  9.15.1 Jiuzhou Pharmaceutical Intermediates Basic Information
  9.15.2 Jiuzhou Pharmaceutical Intermediates Product Overview
  9.15.3 Jiuzhou Pharmaceutical Intermediates Product Market Performance
  9.15.4 Jiuzhou Business Overview
  9.15.5 Jiuzhou Recent Developments
9.16 Yongtai
  9.16.1 Yongtai Pharmaceutical Intermediates Basic Information
  9.16.2 Yongtai Pharmaceutical Intermediates Product Overview
  9.16.3 Yongtai Pharmaceutical Intermediates Product Market Performance
  9.16.4 Yongtai Business Overview
  9.16.5 Yongtai Recent Developments

10 PHARMACEUTICAL INTERMEDIATES MARKET FORECAST BY REGION

10.1 Global Pharmaceutical Intermediates Market Size Forecast
10.2 Global Pharmaceutical Intermediates Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Pharmaceutical Intermediates Market Size Forecast by Country
  10.2.3 Asia Pacific Pharmaceutical Intermediates Market Size Forecast by Region
  10.2.4 South America Pharmaceutical Intermediates Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Pharmaceutical Intermediates by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2022-2028)

11.1 Global Pharmaceutical Intermediates Market Forecast by Type (2022-2028)
  11.1.1 Global Forecasted Sales of Pharmaceutical Intermediates by Type (2022-2028)
  11.1.2 Global Pharmaceutical Intermediates Market Size Forecast by Type (2022-2028)
  11.1.3 Global Forecasted Price of Pharmaceutical Intermediates by Type (2022-2028)
11.2 Global Pharmaceutical Intermediates Market Forecast by Application (2022-2028)
  11.2.1 Global Pharmaceutical Intermediates Sales (K Units) Forecast by Application
  11.2.2 Global Pharmaceutical Intermediates Market Size (M USD) Forecast by Application (2022-2028)

12 CONCLUSION AND KEY FINDINGSLIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmaceutical Intermediates Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Pharmaceutical Intermediates Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Pharmaceutical Intermediates Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Pharmaceutical Intermediates Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Pharmaceutical Intermediates Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Intermediates as of 2021)
Table 10. Global Market Pharmaceutical Intermediates Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Pharmaceutical Intermediates Sales Sites and Area Served
Table 12. Manufacturers Pharmaceutical Intermediates Product Type
Table 13. Global Pharmaceutical Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pharmaceutical Intermediates
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmaceutical Intermediates Market Challenges
Table 22. Market Restraints
Table 23. Global Pharmaceutical Intermediates Sales by Type (K Units)
Table 24. Global Pharmaceutical Intermediates Market Size by Type (M USD)
Table 25. Global Pharmaceutical Intermediates Sales (K Units) by Type (2017-2022)
Table 26. Global Pharmaceutical Intermediates Sales Market Share by Type (2017-2022)
Table 27. Global Pharmaceutical Intermediates Market Size (M USD) by Type (2017-2022)
Table 28. Global Pharmaceutical Intermediates Market Size Share by Type (2017-2022)
Table 29. Global Pharmaceutical Intermediates Price (USD/Unit) by Type (2017-2022)
Table 30. Global Pharmaceutical Intermediates Sales (K Units) by Application
Table 31. Global Pharmaceutical Intermediates Market Size by Application
Table 32. Global Pharmaceutical Intermediates Sales by Application (2017-2022) & (K Units)
Table 33. Global Pharmaceutical Intermediates Sales Market Share by Application (2017-2022)
Table 34. Global Pharmaceutical Intermediates Sales by Application (2017-2022) & (M USD)
Table 35. Global Pharmaceutical Intermediates Market Share by Application (2017-2022)
Table 36. Global Pharmaceutical Intermediates Sales Growth Rate by Application (2017-2022)
Table 37. Global Pharmaceutical Intermediates Sales by Region (2017-2022) & (K Units)
Table 38. Global Pharmaceutical Intermediates Sales Market Share by Region (2017-2022)
Table 39. North America Pharmaceutical Intermediates Sales by Country (2017-2022) & (K Units)
Table 40. Europe Pharmaceutical Intermediates Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Pharmaceutical Intermediates Sales by Region (2017-2022) & (K Units)
Table 42. South America Pharmaceutical Intermediates Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Pharmaceutical Intermediates Sales by Region (2017-2022) & (K Units)
Table 44. Lonza Pharmaceutical Intermediates Basic Information
Table 45. Lonza Pharmaceutical Intermediates Product Overview
Table 46. Lonza Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Lonza Business Overview
Table 48. Lonza Pharmaceutical Intermediates SWOT Analysis
Table 49. Lonza Recent Developments
Table 50. Catalent Pharmaceutical Intermediates Basic Information
Table 51. Catalent Pharmaceutical Intermediates Product Overview
Table 52. Catalent Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Catalent Business Overview
Table 54. Catalent Pharmaceutical Intermediates SWOT Analysis
Table 55. Catalent Recent Developments
Table 56. Patheon Pharmaceutical Intermediates Basic Information
Table 57. Patheon Pharmaceutical Intermediates Product Overview
Table 58. Patheon Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Patheon Business Overview
Table 60. Patheon Pharmaceutical Intermediates SWOT Analysis
Table 61. Patheon Recent Developments
Table 62. Jubilant Pharmaceutical Intermediates Basic Information
Table 63. Jubilant Pharmaceutical Intermediates Product Overview
Table 64. Jubilant Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Jubilant Business Overview
Table 66. Jubilant Pharmaceutical Intermediates SWOT Analysis
Table 67. Jubilant Recent Developments
Table 68. Granules Pharmaceutical Intermediates Basic Information
Table 69. Granules Pharmaceutical Intermediates Product Overview
Table 70. Granules Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Granules Business Overview
Table 72. Granules Pharmaceutical Intermediates SWOT Analysis
Table 73. Granules Recent Developments
Table 74. Ganesh Pharmaceutical Intermediates Basic Information
Table 75. Ganesh Pharmaceutical Intermediates Product Overview
Table 76. Ganesh Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Ganesh Business Overview
Table 78. Ganesh Recent Developments
Table 79. Chemcon Pharmaceutical Intermediates Basic Information
Table 80. Chemcon Pharmaceutical Intermediates Product Overview
Table 81. Chemcon Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Chemcon Business Overview
Table 83. Chemcon Recent Developments
Table 84. BASF Pharmaceutical Intermediates Basic Information
Table 85. BASF Pharmaceutical Intermediates Product Overview
Table 86. BASF Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. BASF Business Overview
Table 88. BASF Recent Developments
Table 89. Porton Pharmaceutical Intermediates Basic Information
Table 90. Porton Pharmaceutical Intermediates Product Overview
Table 91. Porton Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Porton Business Overview
Table 93. Porton Recent Developments
Table 94. Lianhetech Pharmaceutical Intermediates Basic Information
Table 95. Lianhetech Pharmaceutical Intermediates Product Overview
Table 96. Lianhetech Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Lianhetech Business Overview
Table 98. Lianhetech Recent Developments
Table 99. ABA Chem Pharmaceutical Intermediates Basic Information
Table 100. ABA Chem Pharmaceutical Intermediates Product Overview
Table 101. ABA Chem Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. ABA Chem Business Overview
Table 103. ABA Chem Recent Developments
Table 104. Tianma Pharmaceutical Intermediates Basic Information
Table 105. Tianma Pharmaceutical Intermediates Product Overview
Table 106. Tianma Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Tianma Business Overview
Table 108. Tianma Recent Developments
Table 109. Jiujiujiu Pharmaceutical Intermediates Basic Information
Table 110. Jiujiujiu Pharmaceutical Intermediates Product Overview
Table 111. Jiujiujiu Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Jiujiujiu Business Overview
Table 113. Jiujiujiu Recent Developments
Table 114. Alpha Pharmaceutical Intermediates Basic Information
Table 115. Alpha Pharmaceutical Intermediates Product Overview
Table 116. Alpha Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Alpha Business Overview
Table 118. Alpha Recent Developments
Table 119. Jiuzhou Pharmaceutical Intermediates Basic Information
Table 120. Jiuzhou Pharmaceutical Intermediates Product Overview
Table 121. Jiuzhou Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Jiuzhou Business Overview
Table 123. Jiuzhou Recent Developments
Table 124. Yongtai Pharmaceutical Intermediates Basic Information
Table 125. Yongtai Pharmaceutical Intermediates Product Overview
Table 126. Yongtai Pharmaceutical Intermediates Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. Yongtai Business Overview
Table 128. Yongtai Recent Developments
Table 129. Global Pharmaceutical Intermediates Sales Forecast by Region (K Units)
Table 130. Global Pharmaceutical Intermediates Market Size Forecast by Region (M USD)
Table 131. North America Pharmaceutical Intermediates Sales Forecast by Country (2022-2028) & (K Units)
Table 132. North America Pharmaceutical Intermediates Market Size Forecast by Country (2022-2028) & (M USD)
Table 133. Europe Pharmaceutical Intermediates Sales Forecast by Country (2022-2028) & (K Units)
Table 134. Europe Pharmaceutical Intermediates Market Size Forecast by Country (2022-2028) & (M USD)
Table 135. Asia Pacific Pharmaceutical Intermediates Sales Forecast by Region (2022-2028) & (K Units)
Table 136. Asia Pacific Pharmaceutical Intermediates Market Size Forecast by Region (2022-2028) & (M USD)
Table 137. South America Pharmaceutical Intermediates Sales Forecast by Country (2022-2028) & (K Units)
Table 138. South America Pharmaceutical Intermediates Market Size Forecast by Country (2022-2028) & (M USD)
Table 139. Middle East and Africa Pharmaceutical Intermediates Consumption Forecast by Country (2022-2028) & (Units)
Table 140. Middle East and Africa Pharmaceutical Intermediates Market Size Forecast by Country (2022-2028) & (M USD)
Table 141. Global Pharmaceutical Intermediates Sales Forecast by Type (2022-2028) & (K Units)
Table 142. Global Pharmaceutical Intermediates Market Size Forecast by Type (2022-2028) & (M USD)
Table 143. Global Pharmaceutical Intermediates Price Forecast by Type (2022-2028) & (USD/Unit)
Table 144. Global Pharmaceutical Intermediates Sales (K Units) Forecast by Application (2022-2028)
Table 145. Global Pharmaceutical Intermediates Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pharmaceutical Intermediates
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmaceutical Intermediates Market Size (M USD), 2017-2028
Figure 5. Global Pharmaceutical Intermediates Market Size (M USD) (2017-2028)
Figure 6. Global Pharmaceutical Intermediates Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmaceutical Intermediates Market Size (M USD) by Country (M USD)
Figure 11. Pharmaceutical Intermediates Sales Share by Manufacturers in 2020
Figure 12. Global Pharmaceutical Intermediates Revenue Share by Manufacturers in 2020
Figure 13. Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Pharmaceutical Intermediates Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical Intermediates Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pharmaceutical Intermediates Market Share by Type
Figure 18. Sales Market Share of Pharmaceutical Intermediates by Type (2017-2022)
Figure 19. Sales Market Share of Pharmaceutical Intermediates by Type in 2021
Figure 20. Market Size Share of Pharmaceutical Intermediates by Type (2017-2022)
Figure 21. Market Size Market Share of Pharmaceutical Intermediates by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pharmaceutical Intermediates Market Share by Application
Figure 24. Global Pharmaceutical Intermediates Sales Market Share by Application (2017-2022)
Figure 25. Global Pharmaceutical Intermediates Sales Market Share by Application in 2021
Figure 26. Global Pharmaceutical Intermediates Market Share by Application (2017-2022)
Figure 27. Global Pharmaceutical Intermediates Market Share by Application in 2020
Figure 28. Global Pharmaceutical Intermediates Sales Growth Rate by Application (2017-2022)
Figure 29. Global Pharmaceutical Intermediates Sales Market Share by Region (2017-2022)
Figure 30. North America Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Pharmaceutical Intermediates Sales Market Share by Country in 2020
Figure 32. U.S. Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Pharmaceutical Intermediates Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Pharmaceutical Intermediates Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Pharmaceutical Intermediates Sales Market Share by Country in 2020
Figure 37. Germany Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Pharmaceutical Intermediates Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Region in 2020
Figure 44. China Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Pharmaceutical Intermediates Sales and Growth Rate (K Units)
Figure 50. South America Pharmaceutical Intermediates Sales Market Share by Country in 2020
Figure 51. Brazil Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Pharmaceutical Intermediates Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Pharmaceutical Intermediates Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Pharmaceutical Intermediates Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Pharmaceutical Intermediates Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Pharmaceutical Intermediates Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Pharmaceutical Intermediates Market Share Forecast by Type (2022-2028)
Figure 65. Global Pharmaceutical Intermediates Sales Forecast by Application (2022-2028)
Figure 66. Global Pharmaceutical Intermediates Market Share Forecast by Application (2022-2028)